| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |